Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.

The American journal of pathology - 1 Jun 2009

Zhang Xi, Liang Sharon X, Jia Lin, Chen Ning, Fadare Oluwole, Schwartz Peter E, Kong Beihua, Zheng Wenxin

Abstract excerpt

Alteration of p53 is an early event in the development of endometrial serous carcinoma (ESC). We have recently identified a group of benign-looking endometria with p53 overexpression, designated "p53 signatures." In this study, we investigated these p53 signatures and evaluated whether they repre...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cystadenocarcinoma, Serous
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression

Share to Immunohistochemistry

Share to Microdissection

Share to Precancerous Conditions

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 19435786
DOI: 10.2353/ajpath.2009.081085
PMCID: PMC2684165

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-19435786-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.PMID 19435786Read ↗

Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma.Semantic proximity Read ↗

Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.Semantic proximity Read ↗

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.Semantic proximity Read ↗

Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma.Semantic proximity Read ↗

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.Semantic proximity Read ↗

Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations.Semantic proximity Read ↗

A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.Semantic proximity Read ↗

The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma.Semantic proximity Read ↗

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.Semantic proximity Read ↗

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways.Semantic proximity Read ↗

Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.Semantic proximity Read ↗

Aging and uterine serous carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.